ArticleFrontiers in oncology2023

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer.

Jingxia Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.